During the past decade, Peter Morton Medical Building conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Peter Morton Medical Building" are "Carotid Artery Disease" (2 trials), "Acquired Immune Deficiency Syndrome (AIDS)" (1 trials), "HIV Infections" (1 trials) and "Respiratory Tract Infection" (1 trials). Many other conditions were trialed in "Peter Morton Medical Building" in a lesser frequency.

Most popular intervention types in "Peter Morton Medical Building" are "Biological" (1 trials), "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "ATV" (1 trials), "BR" (1 trials), "Cobicistat" (1 trials), "Cobicistat TOS" (1 trials) and "DRV" (1 trials). Other intervention names were less common.

The vast majority of trials in "Peter Morton Medical Building" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Peter Morton Medical Building". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Peter Morton Medical Building, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Peter Morton Medical Building, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".